{"disease":{"id":"neuralgia","name":"Neuralgia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"mirogabalin","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tarlige","generic_name":"MIROGABALIN","company_name":"Daiichi Sankyo","drug_phase":"marketed","molecular_target":"Voltage-dependent calcium channel subunit alpha-2/delta-1","drug_class":"","quality_score":35,"revenue":"300","mechanism":""},{"drug_id":"carbamazepine","indication_name":"Glossopharyngeal Neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tegretol","generic_name":"carbamazepine","company_name":"Novartis AG (originally Geigy)","drug_phase":"marketed","molecular_target":"Frizzled-8, Nuclear receptor subfamily 1 group I member 2, Neuronal acetylcholine receptor; alpha2/beta4","drug_class":"Mood Stabilizer [EPC]","quality_score":62,"revenue":null,"mechanism":"Carbamazepine reduces polysynaptic responses and blocks post-tetanic potentiation, potentially alleviating seizures and pain."},{"drug_id":"lyrica","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lyrica","generic_name":"Pregabalin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"alpha-2-delta subunit (auxiliary subunit of voltage-gated calcium channels)","drug_class":"Anticonvulsant, analgesic","quality_score":10,"revenue":null,"mechanism":"Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS."},{"drug_id":"gabapentin","indication_name":"Postherpetic Neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neurontin","generic_name":"gabapentin","company_name":"Generic (originally Parke-Davis/Pfizer)","drug_phase":"marketed","molecular_target":"Large neutral amino acids transporter small subunit 1, Adenosine receptor A1, Alpha-2A adrenergic receptor","drug_class":"Gabapentinoid (anticonvulsant/neuropathic pain agent)","quality_score":10,"revenue":null,"mechanism":"Binds the alpha-2-delta subunit of voltage-gated calcium channels, modulating neurotransmitter release to treat neuropathic pain and seizures."},{"drug_id":"lyrica","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lyrica","generic_name":"Pregabalin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"alpha-2-delta subunit (auxiliary subunit of voltage-gated calcium channels)","drug_class":"Anticonvulsant, analgesic","quality_score":10,"revenue":null,"mechanism":"Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS."},{"drug_id":"capsaicin","indication_name":"Neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qutenza","generic_name":"CAPSAICIN","company_name":"Averitas","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily V member 1","drug_class":"capsaicin","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"capsaicin","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qutenza","generic_name":"CAPSAICIN","company_name":"Averitas","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily V member 1","drug_class":"capsaicin","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"bat","indication_name":"Treatment of postherpetic neuralgia in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bat","generic_name":"bat","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"carbamazepine","indication_name":"Glossopharyngeal neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tegretol","generic_name":"carbamazepine","company_name":"Novartis AG (originally Geigy)","drug_phase":"marketed","molecular_target":"Frizzled-8, Nuclear receptor subfamily 1 group I member 2, Neuronal acetylcholine receptor; alpha2/beta4","drug_class":"Mood Stabilizer [EPC]","quality_score":62,"revenue":null,"mechanism":"Carbamazepine reduces polysynaptic responses and blocks post-tetanic potentiation, potentially alleviating seizures and pain."},{"drug_id":"carbamazepine","indication_name":"Trigeminal neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tegretol","generic_name":"carbamazepine","company_name":"Novartis AG (originally Geigy)","drug_phase":"marketed","molecular_target":"Frizzled-8, Nuclear receptor subfamily 1 group I member 2, Neuronal acetylcholine receptor; alpha2/beta4","drug_class":"Mood Stabilizer [EPC]","quality_score":62,"revenue":null,"mechanism":"Carbamazepine reduces polysynaptic responses and blocks post-tetanic potentiation, potentially alleviating seizures and pain."},{"drug_id":"lignocaine","indication_name":"Neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lidocaine-hydrochloride","indication_name":"Neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"lidocaine-hydrochloride","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"carbamazepin","indication_name":"Glossopharyngeal neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Carbamazepin","company_name":"Enanta Pharmaceuticals, Inc","drug_phase":"marketed","molecular_target":"Frizzled-8, Nuclear receptor subfamily 1 group I member 2, Neuronal acetylcholine receptor; alpha2/beta4","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"carbamazepin","indication_name":"Trigeminal neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Carbamazepin","company_name":"Enanta Pharmaceuticals, Inc","drug_phase":"marketed","molecular_target":"Frizzled-8, Nuclear receptor subfamily 1 group I member 2, Neuronal acetylcholine receptor; alpha2/beta4","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"gabapentin","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neurontin","generic_name":"gabapentin","company_name":"Generic (originally Parke-Davis/Pfizer)","drug_phase":"marketed","molecular_target":"Large neutral amino acids transporter small subunit 1, Adenosine receptor A1, Alpha-2A adrenergic receptor","drug_class":"Gabapentinoid (anticonvulsant/neuropathic pain agent)","quality_score":10,"revenue":null,"mechanism":"Binds the alpha-2-delta subunit of voltage-gated calcium channels, modulating neurotransmitter release to treat neuropathic pain and seizures."},{"drug_id":"neurontin","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neurontin","generic_name":"Gabapentin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"α2δ subunit of voltage-activated calcium channels","drug_class":"Antiepileptic/Analgesic","quality_score":10,"revenue":null,"mechanism":"Gabapentin binds with high-affinity to α2δ subunit of voltage-activated calcium channels; precise mechanism unknown."},{"drug_id":"gabapentin-enacarbil","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Horizant","generic_name":"GABAPENTIN ENACARBIL","company_name":"Azurity","drug_phase":"marketed","molecular_target":"Voltage-dependent calcium channel subunit alpha-2/delta-1","drug_class":"Anti-epileptic Agent","quality_score":10,"revenue":null,"mechanism":"Horizant works by binding to the alpha-2/delta-1 subunit of voltage-dependent calcium channels, reducing the release of excitatory neurotransmitters and alleviating pain."},{"drug_id":"gabapentine","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"gabapentine","company_name":"Dominik Irnich","drug_phase":"marketed","molecular_target":"Large neutral amino acids transporter small subunit 1, Adenosine receptor A1, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"horizant","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Horizant","company_name":"University of Missouri-Columbia","drug_phase":"marketed","molecular_target":"Voltage-dependent calcium channel subunit alpha-2/delta-1, Voltage-dependent calcium channel subunit alpha-2/delta-2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"carbamazepine","indication_name":"Trigeminal Neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tegretol","generic_name":"carbamazepine","company_name":"Novartis AG (originally Geigy)","drug_phase":"marketed","molecular_target":"Frizzled-8, Nuclear receptor subfamily 1 group I member 2, Neuronal acetylcholine receptor; alpha2/beta4","drug_class":"Mood Stabilizer [EPC]","quality_score":62,"revenue":null,"mechanism":"Carbamazepine reduces polysynaptic responses and blocks post-tetanic potentiation, potentially alleviating seizures and pain."},{"drug_id":"xylocain","indication_name":"Postherpetic neuralgia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":26,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07399288","title":"Postherpetic Neuralgia After Herpes Zoster and Incident Dementia Risk","phase":"","overall_status":"COMPLETED","enrollment_count":68786,"lead_sponsor_name":"China Medical University Hospital","has_results":false},{"nct_id":"NCT07135024","title":"Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular Conflict","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5001,"lead_sponsor_name":"Gerrit A Schubert","has_results":false},{"nct_id":"NCT01256593","title":"Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)","phase":"","overall_status":"COMPLETED","enrollment_count":3827,"lead_sponsor_name":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","has_results":true},{"nct_id":"NCT04846010","title":"Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"All Natural Medicine Clinic, LLC","has_results":false},{"nct_id":"NCT05315596","title":"Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1000,"lead_sponsor_name":"Jena University Hospital","has_results":false},{"nct_id":"NCT07361796","title":"The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster","phase":"NA","overall_status":"RECRUITING","enrollment_count":832,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT05754190","title":"Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Brown University","has_results":false},{"nct_id":"NCT04313335","title":"Duloxetine for PHN","phase":"NA","overall_status":"COMPLETED","enrollment_count":750,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT07238244","title":"Risk Factors for Recurrence of Trigeminal Neuralgia After Percutaneous Balloon Compression","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":700,"lead_sponsor_name":"Second Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT01713426","title":"A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":568,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":false},{"nct_id":"NCT06071936","title":"Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":558,"lead_sponsor_name":"Apurano Pharmaceuticals GmbH","has_results":false},{"nct_id":"NCT06071975","title":"Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":558,"lead_sponsor_name":"Apurano Pharmaceuticals GmbH","has_results":false},{"nct_id":"NCT06072573","title":"Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":558,"lead_sponsor_name":"Apurano Pharmaceuticals GmbH","has_results":false},{"nct_id":"NCT06071988","title":"Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":558,"lead_sponsor_name":"Apurano Pharmaceuticals GmbH","has_results":false},{"nct_id":"NCT04560361","title":"The Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia","phase":"NA","overall_status":"COMPLETED","enrollment_count":448,"lead_sponsor_name":"Nanjing University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT04774458","title":"Prospective Observation of the Fluoroscopy-guided Cervical Epidural Approach Using the Contralateral Oblique View","phase":"NA","overall_status":"COMPLETED","enrollment_count":439,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT06518421","title":"Emotion and Memory in Chronic Neuropathic Pain","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT05140863","title":"To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT03186443","title":"Pregabalin Treatment and Prevention Post-herpetic Neuralgia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":342,"lead_sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT05763550","title":"To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":331,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT01252160","title":"Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT02365636","title":"A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Teva Branded Pharmaceutical Products R&D, Inc.","has_results":true},{"nct_id":"NCT06410222","title":"Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"Feng Gao","has_results":false},{"nct_id":"NCT06472323","title":"The Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet-rich Plasma for the Trigeminal Neuralgia","phase":"","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT03745404","title":"A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"Grünenthal GmbH","has_results":false},{"nct_id":"NCT03765697","title":"A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":259,"lead_sponsor_name":"Grünenthal GmbH","has_results":false},{"nct_id":"NCT03593330","title":"Neurosurgical Transitional Care Programme","phase":"NA","overall_status":"TERMINATED","enrollment_count":242,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT06410859","title":"Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal Neuralgia","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":240,"lead_sponsor_name":"LKGS_277","has_results":false},{"nct_id":"NCT06492213","title":"The Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet-rich Plasma for Infraorbital Neuralgia","phase":"","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04570293","title":"5% Lidocaine-medicated Plaster for the Treatment of Trigeminal Neuralgia","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":226,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04467398","title":"Incidence of Intravascular (IV) Injection During Trigeminal Nerve Blocks","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Seoul National University","has_results":false},{"nct_id":"NCT03386058","title":"Examining Carryover Effect in Patients Treated witH Spinal cOrd Stimulation (ECHO)","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06914193","title":"Esketamine Combined With PRF of DRG for Postherpetic Neuralgia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":186,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT05870124","title":"Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":185,"lead_sponsor_name":"Nalu Medical, Inc.","has_results":false},{"nct_id":"NCT07123402","title":"To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":184,"lead_sponsor_name":"Beijing Tide Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT03708653","title":"Single Nucleotide Polymorphisms (SNPs) Associated With Postherpetic Neuralgia","phase":"","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06890897","title":"Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia","phase":"NA","overall_status":"RECRUITING","enrollment_count":174,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT06914180","title":"Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":174,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT05217628","title":"An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":166,"lead_sponsor_name":"Noema Pharma AG","has_results":false},{"nct_id":"NCT05568186","title":"Correlation Between Thermal Patterns of Infrared Thermal Imaging and Clinical Phenotype in Patients With Postherpetic Neuralgia","phase":"","overall_status":"UNKNOWN","enrollment_count":166,"lead_sponsor_name":"Xianwei Zhang，MD","has_results":false},{"nct_id":"NCT07068451","title":"Greater Occipital Nerve Block Alone Versus Dual Nerve Block in Cervicogenic Headache and Occipital Neuralgia","phase":"NA","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Tishreen University Hospital","has_results":false},{"nct_id":"NCT07275762","title":"Y-4 to Treat the Postherpetic Neuralgia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Neurodawn Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04184596","title":"Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP)","phase":"","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"LinkCare GmbH","has_results":false},{"nct_id":"NCT00160667","title":"A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"UCB Pharma","has_results":true},{"nct_id":"NCT07038707","title":"Early Screening Markers of Herpes Zoster Neuralgia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT03331913","title":"Botulinum Toxin for Trigeminal Neuralgia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"The First Affiliated Hospital of Zhengzhou University","has_results":false},{"nct_id":"NCT07046247","title":"Impact of Teflon Technique on Recurrence After Microvascular Decompression for Trigeminal Neuralgia","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"University of Valencia","has_results":false},{"nct_id":"NCT06896994","title":"Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04174443","title":"The Efficacy and Safety of Pulsed Radiofrequency Combined With Continuous Radiofrequency for the Trigeminal Neuralgia","phase":"NA","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04924348","title":"WALANT Procedure in Carpal Tunnel Release","phase":"NA","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"Elsan","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}